Towards a bioengineered uterus: bioactive sheep uterus scaffolds are effectively recellularized by enzymatic preconditioning

Uterine factor infertility was considered incurable until recently when we reported the first successful live birth after uterus transplantation. However, risky donor surgery and immunosuppressive therapy are factors that may be avoided with bioengineering. For example, transplanted recellularized c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Padma, Arvind Manikantan (VerfasserIn) , Carrière, Laura (VerfasserIn) , Krokström Karlsson, Frida (VerfasserIn) , Sehic, Edina (VerfasserIn) , Bandstein, Sara (VerfasserIn) , Tiemann, Tom Tristan (VerfasserIn) , Oltean, Mihai (VerfasserIn) , Song, Min Jong (VerfasserIn) , Brännström, Mats (VerfasserIn) , Hellström, Mats (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 21 May 2021
In: npj regenerative medicine
Year: 2021, Jahrgang: 6, Heft: 1, Pages: 1-11
ISSN:2057-3995
DOI:10.1038/s41536-021-00136-0
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41536-021-00136-0
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41536-021-00136-0
Volltext
Verfasserangaben:Arvind Manikantan Padma, Laura Carrière, Frida Krokström Karlsson, Edina Sehic, Sara Bandstein, Tom Tristan Tiemann, Mihai Oltean, Min Jong Song, Mats Brännström and Mats Hellström

MARC

LEADER 00000caa a2200000 c 4500
001 1760984450
003 DE-627
005 20220820000221.0
007 cr uuu---uuuuu
008 210622s2021 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41536-021-00136-0  |2 doi 
035 |a (DE-627)1760984450 
035 |a (DE-599)KXP1760984450 
035 |a (OCoLC)1341416623 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Padma, Arvind Manikantan  |e VerfasserIn  |0 (DE-588)1157040535  |0 (DE-627)1020039965  |0 (DE-576)502595736  |4 aut 
245 1 0 |a Towards a bioengineered uterus  |b bioactive sheep uterus scaffolds are effectively recellularized by enzymatic preconditioning  |c Arvind Manikantan Padma, Laura Carrière, Frida Krokström Karlsson, Edina Sehic, Sara Bandstein, Tom Tristan Tiemann, Mihai Oltean, Min Jong Song, Mats Brännström and Mats Hellström 
264 1 |c 21 May 2021 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.06.2021 
520 |a Uterine factor infertility was considered incurable until recently when we reported the first successful live birth after uterus transplantation. However, risky donor surgery and immunosuppressive therapy are factors that may be avoided with bioengineering. For example, transplanted recellularized constructs derived from decellularized tissue restored fertility in rodent models and mandate translational studies. In this study, we decellularized whole sheep uterus with three different protocols using 0.5% sodium dodecyl sulfate, 2% sodium deoxycholate (SDC) or 2% SDC, and 1% Triton X-100. Scaffolds were then assessed for bioactivity using the dorsal root ganglion and chorioallantoic membrane assays, and we found that all the uterus scaffolds exhibited growth factor activity that promoted neurogenesis and angiogenesis. Extensive recellularization optimization was conducted using multipotent sheep fetal stem cells and we report results from the following three in vitro conditions; (a) standard cell culturing conditions, (b) constructs cultured in transwells, and (c) scaffolds preconditioned with matrix metalloproteinase 2 and 9. The recellularization efficiency was improved short-term when transwells were used compared with standard culturing conditions. However, the recellularization efficiency in scaffolds preconditioned with matrix metalloproteinases was 200-300% better than the other strategies evaluated herein, independent of decellularization protocol. Hence, a major recellularization hurdle has been overcome with the improved recellularization strategies and in vitro platforms described herein. These results are an important milestone and should facilitate the production of large bioengineered grafts suitable for future in vivo applications in the sheep, which is an essential step before considering these principles in a clinical setting. 
700 1 |a Carrière, Laura  |e VerfasserIn  |4 aut 
700 1 |a Krokström Karlsson, Frida  |e VerfasserIn  |4 aut 
700 1 |a Sehic, Edina  |e VerfasserIn  |4 aut 
700 1 |a Bandstein, Sara  |e VerfasserIn  |4 aut 
700 1 |a Tiemann, Tom Tristan  |e VerfasserIn  |0 (DE-588)1157040632  |0 (DE-627)1020950374  |0 (DE-576)502595671  |4 aut 
700 1 |a Oltean, Mihai  |e VerfasserIn  |4 aut 
700 1 |a Song, Min Jong  |e VerfasserIn  |4 aut 
700 1 |a Brännström, Mats  |e VerfasserIn  |4 aut 
700 1 |a Hellström, Mats  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t npj regenerative medicine  |d [London] : Nature Publishing Group, 2016  |g 6(2021), 1, Artikel-ID 26, Seite 1-11  |h Online-Ressource  |w (DE-627)876318367  |w (DE-600)2879698-6  |w (DE-576)481567798  |x 2057-3995  |7 nnas  |a Towards a bioengineered uterus bioactive sheep uterus scaffolds are effectively recellularized by enzymatic preconditioning 
773 1 8 |g volume:6  |g year:2021  |g number:1  |g elocationid:26  |g pages:1-11  |g extent:11  |a Towards a bioengineered uterus bioactive sheep uterus scaffolds are effectively recellularized by enzymatic preconditioning 
856 4 0 |u https://doi.org/10.1038/s41536-021-00136-0  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41536-021-00136-0  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210622 
993 |a Article 
994 |a 2021 
998 |g 1157040632  |a Tiemann, Tom Tristan  |m 1157040632:Tiemann, Tom Tristan  |p 6 
999 |a KXP-PPN1760984450  |e 3940644552 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Arvind Manikantan","family":"Padma","role":"aut","roleDisplay":"VerfasserIn","display":"Padma, Arvind Manikantan"},{"roleDisplay":"VerfasserIn","display":"Carrière, Laura","role":"aut","family":"Carrière","given":"Laura"},{"family":"Krokström Karlsson","given":"Frida","roleDisplay":"VerfasserIn","display":"Krokström Karlsson, Frida","role":"aut"},{"given":"Edina","family":"Sehic","role":"aut","display":"Sehic, Edina","roleDisplay":"VerfasserIn"},{"display":"Bandstein, Sara","roleDisplay":"VerfasserIn","role":"aut","family":"Bandstein","given":"Sara"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Tiemann, Tom Tristan","given":"Tom Tristan","family":"Tiemann"},{"role":"aut","display":"Oltean, Mihai","roleDisplay":"VerfasserIn","given":"Mihai","family":"Oltean"},{"family":"Song","given":"Min Jong","roleDisplay":"VerfasserIn","display":"Song, Min Jong","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Brännström, Mats","given":"Mats","family":"Brännström"},{"family":"Hellström","given":"Mats","display":"Hellström, Mats","roleDisplay":"VerfasserIn","role":"aut"}],"title":[{"title_sort":"Towards a bioengineered uterus","subtitle":"bioactive sheep uterus scaffolds are effectively recellularized by enzymatic preconditioning","title":"Towards a bioengineered uterus"}],"language":["eng"],"recId":"1760984450","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 22.06.2021"],"name":{"displayForm":["Arvind Manikantan Padma, Laura Carrière, Frida Krokström Karlsson, Edina Sehic, Sara Bandstein, Tom Tristan Tiemann, Mihai Oltean, Min Jong Song, Mats Brännström and Mats Hellström"]},"id":{"eki":["1760984450"],"doi":["10.1038/s41536-021-00136-0"]},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"21 May 2021"}],"relHost":[{"pubHistory":["1, Article number 16001 (June 2016)-"],"part":{"year":"2021","issue":"1","pages":"1-11","text":"6(2021), 1, Artikel-ID 26, Seite 1-11","volume":"6","extent":"11"},"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 10.01.2017"],"disp":"Towards a bioengineered uterus bioactive sheep uterus scaffolds are effectively recellularized by enzymatic preconditioningnpj regenerative medicine","language":["eng"],"recId":"876318367","title":[{"title":"npj regenerative medicine","title_sort":"npj regenerative medicine"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"09 June 2016-","publisher":"Nature Publishing Group","publisherPlace":"[London]"}],"id":{"eki":["876318367"],"zdb":["2879698-6"],"issn":["2057-3995"]}}],"physDesc":[{"extent":"11 S."}]} 
SRT |a PADMAARVINTOWARDSABI2120